Press Releases in 2010

Littleton, CO - October 13th, 2010 - ColoradoBiz ranked Novus Biologicals no. 107 on its list of the Top 250 Private Companies in Colorado.  This list represents Colorado private companies that weathered the recession and continue to grow and thrive in a down economy.

USP9x is an ubiquitin-specific protease involved in the removal and recycling of ubiquitin from proteins degraded in proteasomes.  Novus Biologicals just introduced a new anti-USP9x antibody (catalog # NBP1-48321), as well as the USPx blocking peptide (catalog # NBP1-48321PEP).

One new Blooms Syndrome Protein (BLM) antibody made to a phosphorylated site was recently introduced to the bioscience research industry by Novus Biologicals.  The Blm [phospho Thr99] antibody (catalog # NBP1-46851) recognizes the Bloom Syndrome Protein at threonine 99.  This new pBLM antibody has been twice published and is backed by Novus' Guarantee + Innovator’s Rewardâ„¢ Policy.

N Cadherin antibodies are plasma membrane markers and have recently been identified as potential prognostic tumor markers. Novus Biologicals just released a new N Cadherin antibody (catalog # NBP1-48309). This new N-Cadherin antibody cross-reacts with human and mouse, and is useful for Immunoprecipitation, Immunofluorescence and Western blot analysis.

Novus Biologicals' new PKM2 antibody (NBP1-48308) is useful for the study of cancer metabolism and bacterial pathogenesis.  This rabbit polyclonal anti-PKM2 antibody cross-reacts with bovine, human, mouse and rat and has been validated for use in immunocytochemistry and

Novus Biologicals just launched a new Survivin Antibody (NBP1-47639) that is made to a synthetic peptide surrounding the acetylated lysine 129 of the human Survivin protein.  It has recently been shown that Survivin acetylation at amino acid 129 affects its interaction with STAT3, determines its interaction with CRM1 and its subsequent subcellular localization (PMID: 20826784).

Novus Biologicals' newest antibody, an Estrogen Related Receptor Alpha Antibody (catalog # NBP1-47254) is suitable for use in Immunocytochemistry and Western blot analysis.  The ERR al

Novus Biologicals recently launched five new proteins that are of special interest to the bioresearch community due to their high efficacy in Western blot analysis.  These five proteins include: Tyrosine Hydroxylase Protein, FUS Protein,  Nanog Protein, H2AX Protein and Ubiquitin Protein.

Novus Biologicals just released four new HIF-1 alpha antibodies, specific to various HIF exons (exon 9: NBP1-47178, exon 10: NBP1-47179, exon 12: NBP1-47180, exon 13: NBP1-47181). These new exon specific HIF-1 Alpha antibodies have been positively validated for use in Western blot and cross-react with human.  

Novus Biologicals just released two new SNX27 antibodies (NBP1-45282 and NBP1-45283) for use in Western blot and immunocytochemistry/immunofluorescence. These rabbit polyclonal antibodies are affinity purified and their immunogens are synthetic peptides made to internal portions of the human SNX27 protein (Swiss-Prot# Q96L92).